MARY BROWNING: Open Payments
NPI 1013498849 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,159 in 54 payments from 23 companies in 2025. Trend: 2023 $1,383 · 2024 $1,116 · 2025 $1,159
Food & beverage: $1,159
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $163 |
| Merck Sharp & Dohme LLC | 5 | $113 |
| ABBVIE INC. | 5 | $113 |
| Novartis Pharmaceuticals Corporation | 6 | $108 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| Pharmacosmos Therapeutics Inc. | 2 | $48 |
| Incyte Corporation | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Stemline Therapeutics Inc. | 2 | $44 |
Products named: EPKINLY, KEYTRUDA, OPDIVO, DARZALEX, PLUVICTO, ERLEADA, MONOFERRIC, MONJUVI.
Industry payments across FL — which companies pay providers there.
